Oral Presentation (O06) | BioBehçet’s: Optimal utilisation of biologic drugs in Behçet’s Disease: a randomised controlled trial of infliximab vs alpha interferon, with genotyping and metabolomic profiling, towards a stratified medicines approach to treatment

Save my name, email, and website in this browser for the next time I comment.

By using this form you agree with the storage and handling of your data by this website. *

Δ